Olanzapine Impact on First-line Immunotherapy for Advanced EGFR-negative NSCLC
Clinical trial NCT06554613 · RECRUITING
Trial details
- NCT number
- NCT06554613
- Sponsor
- Second Affiliated Hospital of Nanchang University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-02
- Primary completion
- 2026-12-01
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.